竞争性酸阻塞剂与侵蚀性食道炎的质子抑制剂:系统性审查和网络元分析
Jin Won Chang1, Da Hyun Jung1, Nak-Hoon Son2
1Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Journal of neurogastroenterology and motility
|March 13, 2026
概括
竞争性酸阻断剂 (P-CABs) 比质子抑制剂 (PPI) 更有效治疗侵蚀性食道炎 (EE),特别是严重的病例. P-CABs,特别是vonoprazan,为EE管理提供了更高的疗效和安全性.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学 是一个学科.
- 临床医学 临床医学
背景情况:
- 竞争性酸阻断剂 (P-CABs) 正在成为治疗侵蚀性食道炎 (EE) 的质子抑制剂 (PPI) 的替代品.
- 这项研究比较了P-CABs和PPI在轻度至重度EE患者的疗效和安全性,按治疗阶段分层.
研究的目的:
- 为了比较P-CABs与PPI在治疗侵蚀性食道炎 (EE) 的疗效和安全性.
- 根据治疗阶段 (初始与维持) 和EE严重程度分层发现.
主要方法:
- 在PubMed,MEDLINE和Cochrane控制试验中央注册表中进行系统的文献搜索.
- 包括随机对照试验,比较P-CAB和EE的PPI.
- 频率网络元分析以计算聚合风险比率 (RRs) 和风险差异,并为治疗排名提供P-score.
主要成果:
- 分析了19项涉及5种P-CAB和2种PPI的研究.
- 在最初阶段,P-CABs显示出优异的愈合效果,特别是在严重的EE (RR = 1.10) 中.
- 在维持期间,P-CABs表现出较低的EE复发风险 (RR = 0.59),诺普拉桑排名最高.
结论:
- P-CABs,特别是vonoprazan,在EE的初始和维持治疗中表现出比PPI更高的疗效.
- 研究结果支持P-CAB作为EE管理的可靠一线选择,特别是在高风险患者中.
- 在P-CAB和PPI之间观察到可比的安全概况.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
1.4K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
1.3K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.3K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
1.1K
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
1.1K
Gastroesophageal Reflux Disease II: Clinical Features and Management
1.1K
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.1K
Barrett Esophagus-II: Clinical Manifestations and Management
1.8K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.8K
Peptic Ulcer Disease IV: Management
807
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
807


